Jean Francois Formela Intellia Therapeutics, Inc. (NTLA) insider trading activity

Jean Francois Formela is Director of Intellia Therapeutics, Inc.. Currently has a direct ownership of 7,291 shares of NTLA, which is worth approximately $88,804. The most recent transaction as insider was on Jun 14, 2022, when has been sold 5,197 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.29K

0% 3M change

0% 12M change

Total Value Held $88,804

JEAN FRANCOIS FORMELA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 14 2022	BUY Grant, award, or other acquisition	-	5,197 Added 41.62%	7,291 Common Stock
Jun 23 2021	BUY Grant, award, or other acquisition	-	2,094 Added 50.0%	2,094 Common Stock

Also insider at

SPRO

Spero Therapeutics, Inc. Healthcare

Director

TBIO

Translate Bio, Inc. Healthcare

Director

IKNA

Ikena Oncology, Inc. Healthcare

FREQ

Frequency Therapeutics, Inc. Healthcare

JFF